Agonist-specific cross talk between ERKs and p38mapk regulates PGI2 synthesis in endothelium

American Journal of Physiology - Cell Physiology

Volumn 281, Issue 4 50-4, 2001, Pages

  Houliston, Rebecca A ^a   Pearson, Jeremy D ^b   Wheeler Jones, Caroline P D ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cytosolic phospholipase A2 ; Extracellular signal regulated kinase; Human endothelium; Interleukin 1; Mitogen activated protein kinases; Prostacyclin; Thrombin

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ARACHIDONIC ACID; INTERLEUKIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE A2 INHIBITOR; PROSTACYCLIN; THROMBIN;

ARTICLE; CELL CULTURE; ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME ANALYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROSTAGLANDIN SYNTHESIS; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM;

EID: 0034785691     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.2001.281.4.c1266     Document Type: Article

References (51)

1. 2 inhibit release of free arachidonic acid in thrombin-stimulated human platelets
2. 2 in agonist-stimulated human platelets and HeLa cells
3. 2 is phosphorylated in collagen- and thrombin-stimulated human platelets independent of protein kinase C and mitogen-activated protein kinase
4. Direct inhibition of cyclooxygenase-1 and -2 by kinase inhibitors SB203580 and PD98059. SB203580 also inhibits thromboxane synthase
5. Interleukin-1 stimulates prostacyclin production by cultured human endothelial cells by increasing arachidonic acid mobilisation and conversion
6. Rate of vasoconstrictor prostanoids released by endothelial cells depends on cyclooxygenase-2 expression and prostaglandin I synthase activity
7. Regulation of P(2y)-purinoceptor-mediated prostacyclin release from human endothelial cells by cytoplasmic calcium concentration
8. Regulation of prostacyclin synthesis in endothelial cells
9. A synthetic inhibitor of the mitogen-activated protein kinase cascade
10. Identification of a novel inhibitor of mitogen-activated protein kinase kinase
11. Interleukin 1-stimulated prostacyclin synthesis in endothelium- lack of phospholipase-C, phospholipase-D, or protein-kinase-C involvement in early signal transduction
12. 2 is required for macrophage arachidonic acid release by agonists that do and do not mobilise calcium
13. 2 by p42 mitogen-activated protein kinase results in an increase in specific activity
14. 2 by MNK1-related protein kinase
15. Human cyclooxygenase-2 cDNA
16. Culture of human umbilical endothelial cells derived from umbilical veins
17. Raf-1 is activated by p38 mitogen-activated protein kinase inhibitor, SB203580
18. 2
19. Novel homologues of CSBP/p38 MAP kinase: Activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles
20. + exchange and ERK1/2
21. 2
22. The stress inducer arsenite activates mitogen-activated protein kinases extracellular signal-related kinases 1 and 2 via a MAPK kinase 6/p38-dependent pathway
23. An endothelial cell growth factor from bovine hypothalamus: Identification and partial characterization
24. Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells
25. The regulation of tyrosine kinase signalling pathways by growth factor and G-protein-coupled receptors
26. 2 and arachidonic acid to prostacyclin by cultured human endothelial cells
27. 2 does not alter leukotriene formation
28. mapk in human umbilical vein endothelial cells by interleukin-1α and tumor necrosis factor-α
29. Requirement of p38 mitogen-activated protein kinase for neuronal differentiation in PC12 cells
30. 2 binds with high affinity and specificity to phosphatidylinositol 4,5-bisphosphate resulting in dramatic increases in activity
31. 2
32. 2α
33. 2 by p42 microtubule-associated protein 2 kinase and protein kinase C
34. 2 underlies the receptor stimulation of arachidonic acid-dependent noncapacitative calcium entry
35. 2
36. 2 in regulating arachidonic acid release in macrophages
37. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine
38. Tumour necrosis factor α induced E-selectin expression is activated by the nuclear factor-κB and c-jun N-terminal kinase/p38 mitogen-activated protein kinase pathways
39. 2 to the nuclear envelope and endoplasmic reticulum
40. 2-β
41. Mitogen-activated protein kinase cascades and regulation of gene expression
42. 2
43. 2 are abrogated by an inhibitor of the p38 mitogen-activated protein kinase cascade in human neutrophils
44. 2 in endothelial cells via p42/p44 mitogen-activated protein kinase
45. 2 release but has no effect on von Willebrand factor secretion or E-selectin expression
46. Protein tyrosine kinases regulate agonist-stimulated prostacyclin release but not von Willebrand factor secretion from human umbilical vein endothelial cells
47. 2
48. 2 phosphorylation and eicosanoid production by colony-stimulating factor 1
49. Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site
50. Mitogen-activated protein (MAP) kinase regulates production of tumor necrosis factor-α and release of arachidonic acid in mast cells. Indications of communication between p38 and p42 MAP kinases
51. Stress induced inhibition of ERK1 and ERK2 by direct interaction with p38 MAP kinase